ACS San Diego 2019: Day 2

Throughout this week, RxNet is bringing you content, direct from the ACS San Diego 2019 (25–29 August 2019; CA, USA). Take a look at some of the highlights, including some of the key presentations and news from the meeting.

Like 0 Comment

Today’s key talks

  1. Coupling the 1D, 2D, and 3D data worlds to facilitate drug discovery (Monday, 26 August; 8:35 –9:05) – Daniel Fred Ortwine (Genentech; CA, USA) 
  2. PROTAC™ targeted protein degraders: Exciting modality for drug discovery (Monday, 26 August; 10:20 AM – 10:50 AM) – Erika Araujo (Arvina; CT, USA) 
  3. Enabling medicinal chemistry as a process chemist (Monday, 26 August; 11:20 – 11:50 AM) – Jamie McCabe Dunn (Merck; NJ, USA)

News highlight

  Remodeling the microbiome for atherosclerosis therapy

What to look out for tomorrow

  1. Geminal diheteroatomic motifs in drug design: Applications of acetals, ketals, and their sulfur and nitrogen homologues in medicinal chemistry (Tuesday, 27 August; 3:05 – 3:35 PM) – Yong-Jun Wu (Bristol-Myers Squibb; MA, USA) 
  2. Translational Chemistry (Tuesday, 27 August; 9:00—9:45 AM) – Phil S Baran (Scripps Research; CA, USA)

Don't forget to visit RxNet at booth #1335 to get your free copy of our brand new glossary!

Go to the profile of RxNet


A network for the drug discovery and development community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.